11-60842540-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024098.4(CCDC86):c.416C>T(p.Ala139Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A139T) has been classified as Uncertain significance.
Frequency
Consequence
NM_024098.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC86 | ENST00000227520.10 | c.416C>T | p.Ala139Val | missense_variant | Exon 1 of 4 | 1 | NM_024098.4 | ENSP00000227520.5 | ||
CCDC86 | ENST00000535217.1 | n.259+136C>T | intron_variant | Intron 1 of 4 | 5 | ENSP00000442111.1 | ||||
CCDC86-AS1 | ENST00000538705.1 | n.317-560G>A | intron_variant | Intron 1 of 1 | 3 | |||||
ENSG00000255959 | ENST00000539897.1 | n.349+77G>A | intron_variant | Intron 1 of 1 | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249560Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135270
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461328Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726956
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.416C>T (p.A139V) alteration is located in exon 1 (coding exon 1) of the CCDC86 gene. This alteration results from a C to T substitution at nucleotide position 416, causing the alanine (A) at amino acid position 139 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at